TY - JOUR
T1 - Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation
AU - Bergoeing, Michel P.
AU - Arif, Batool
AU - Hackmann, Amy E.
AU - Ennis, Terri L.
AU - Thompson, Robert W.
AU - Curci, John A.
N1 - Funding Information:
We would like to thank Dave K. Kobayashi, BA, from the Department of Pediatrics, Division of Pulmonary and Critical Care Medicine, the Washington University School of Medicine for his assistance in the cigarette-smoke exposure of the mice. We also wish to thank Clay F. Semenkovich, MD, director of the CNRU Animal Model Research Core at Washington University School of Medicine, for his assistance in blood pressure monitoring, supported by NIH grant DK56341.
Funding Information:
Supported by a grant from the Flight Attendants Medical Research Institute.
PY - 2007/6
Y1 - 2007/6
N2 - Objective: The development of abdominal aortic aneurysms (AAA) is presumed to result from multiple genetic and environmental factors, with exposure to tobacco smoke the single largest known factor predisposing to aneurysm growth. We have attempted to adapt the elastase-perfused animal model to determine whether tobacco exposure can lower the threshold of aortic injury necessary for AAA development. Methods: Adult C57BL/6 mice underwent transient perfusion of the infrarenal aorta with an active solution of elastase: high-dose (HDE, 0.19 U/mL, n = 9), standard-dose (SDE, 0.16 U/mL, n = 21) or low-dose (LDE, 0.07 U/mL, n = 24). Control animals (n = 24) were treated with heat inactivated elastase (HIE). Twenty LDE perfused mice were exposed to cigarette smoke (LDE-S) beginning 2 weeks before perfusion and continuing until aortic harvest. Aortic diameter (AD) was measured preperfusion, postperfusion, and at harvest on day 14. AAA was defined as %ΔAD ≥100% between preperfusion and harvest. Aortas from each group (except HDE) were analyzed for matrix metalloproteinase-9 (MMP-9) and MMP-12 expression by real-time polymerase chain reaction normalized to glyceraldehyde-3-phosphate dehydrogenase. Results: All SDE mice developed large AAA by %ΔAD (189.3% ± 16.9%, mean ± standard error of the mean), but control mice had only a small dilatation (69.7% ± 3.7%, P < .01). Higher doses of elastase did not produce larger aneurysms in HDE mice. In contrast, only 63% of LDE mice showed aneurysmal dilatation, and these were significantly smaller (104.3% ± 4.2%, P < .01). When exposed to cigarette smoke, LDE animals developed significantly larger aneurysms (%ΔAD, 134.5% ± 7.9%, P = .0021). There was no difference in normalized aortic MMP-9 and MMP-12 expression between elastase doses or between smoke-exposed and unexposed animals. Histologic analysis revealed that smoking increased the extent of aortic elastin degradation when compared with LDE-S animals. Conclusion: Aneurysm development in the elastase model is dependent on the quantity of active elastase infused. Exposure of animals to tobacco smoke after a relatively minor aortic elastase injury produces increases in elastin degradation and aneurysm size without affecting MMP-9 or MMP-12 expression. To our knowledge, this is the first demonstration in an animal model that smoking can act as a synergistic factor in AAA development. Further understanding of the relationship between smoking and AAA in this model may help unveil the pathophysiologic pathways involved between cigarette smoke and AAAs.
AB - Objective: The development of abdominal aortic aneurysms (AAA) is presumed to result from multiple genetic and environmental factors, with exposure to tobacco smoke the single largest known factor predisposing to aneurysm growth. We have attempted to adapt the elastase-perfused animal model to determine whether tobacco exposure can lower the threshold of aortic injury necessary for AAA development. Methods: Adult C57BL/6 mice underwent transient perfusion of the infrarenal aorta with an active solution of elastase: high-dose (HDE, 0.19 U/mL, n = 9), standard-dose (SDE, 0.16 U/mL, n = 21) or low-dose (LDE, 0.07 U/mL, n = 24). Control animals (n = 24) were treated with heat inactivated elastase (HIE). Twenty LDE perfused mice were exposed to cigarette smoke (LDE-S) beginning 2 weeks before perfusion and continuing until aortic harvest. Aortic diameter (AD) was measured preperfusion, postperfusion, and at harvest on day 14. AAA was defined as %ΔAD ≥100% between preperfusion and harvest. Aortas from each group (except HDE) were analyzed for matrix metalloproteinase-9 (MMP-9) and MMP-12 expression by real-time polymerase chain reaction normalized to glyceraldehyde-3-phosphate dehydrogenase. Results: All SDE mice developed large AAA by %ΔAD (189.3% ± 16.9%, mean ± standard error of the mean), but control mice had only a small dilatation (69.7% ± 3.7%, P < .01). Higher doses of elastase did not produce larger aneurysms in HDE mice. In contrast, only 63% of LDE mice showed aneurysmal dilatation, and these were significantly smaller (104.3% ± 4.2%, P < .01). When exposed to cigarette smoke, LDE animals developed significantly larger aneurysms (%ΔAD, 134.5% ± 7.9%, P = .0021). There was no difference in normalized aortic MMP-9 and MMP-12 expression between elastase doses or between smoke-exposed and unexposed animals. Histologic analysis revealed that smoking increased the extent of aortic elastin degradation when compared with LDE-S animals. Conclusion: Aneurysm development in the elastase model is dependent on the quantity of active elastase infused. Exposure of animals to tobacco smoke after a relatively minor aortic elastase injury produces increases in elastin degradation and aneurysm size without affecting MMP-9 or MMP-12 expression. To our knowledge, this is the first demonstration in an animal model that smoking can act as a synergistic factor in AAA development. Further understanding of the relationship between smoking and AAA in this model may help unveil the pathophysiologic pathways involved between cigarette smoke and AAAs.
UR - http://www.scopus.com/inward/record.url?scp=34249287028&partnerID=8YFLogxK
U2 - 10.1016/j.jvs.2007.01.058
DO - 10.1016/j.jvs.2007.01.058
M3 - Article
C2 - 17398058
AN - SCOPUS:34249287028
SN - 0741-5214
VL - 45
SP - 1217-1227.e2
JO - Journal of Vascular Surgery
JF - Journal of Vascular Surgery
IS - 6
ER -